Synaptic deprivation and age-related vulnerability to hypoxic-ischemic neuronal injury: A hypothesis

Annals of the New York Academy of Sciences

Volumn 939, Issue , 2001, Pages 238-253

  Marini, Ann M ^a   Choi, John ^a,b   Labutta, Robert ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Age related vulnerability; Excitatory amino acids; Hypoxic ischemic neuronal injury; Intrinsic survival pathways; NMDA receptors; Plasticity; Synaptic deprivation

Indexed keywords

EXCITATORY AMINO ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; POSTSYNAPTIC MEMBRANE; RAT; SYNAPSE;

EID: 0034944621     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03631.x     Document Type: Conference Paper

References (94)

1. The prevalence of vascular dementia in Europe: Facts and fragments from 1980-1990 studies
2. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham heart study
3. Atrila fibrillation and cognitive function: Final results
4. Chronic atrial fibrillation and low cognitive function
5. Atrial fibrillation is an independent determinant of low cognitive function: A cross-sectional study in elderly men
6. Atrial fibrillation and dementia in a population-based study. The Rotterdam study
7. Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke
8. Internal borderzone infarction: A marker for severe stenosis in patients with symptomatic internal carotid artery disease. For the North American Symptomatic Carotid Endarterectomy (NASCET) Group
9. Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia
10. Cerebral circulation in the elderly
11. Observations on the brains of demented old people
12. Clinical factors associated with dementia in ischemic stroke
13. Clinical determinants of dementia related to stroke
14. Intellectual impairment and cerebral lesions in multiple cerebral infarcts. A clinical-computed tomography study
15. CT and MRI findings among African-Americans with Alzheimer's disease, vascular dementia, and stroke without dementia
16. Risk factors for dementia associated with multiple cerebral infarcts: A case-control analysis in predominantly African-American hospital-based patients
17. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort
18. The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham cohort
19. Vascular dementia, hypertension, and the brain
20. Cranial computed tomography in ischemic stroke patients with and without dementia-a prospective study
21. Brain infarction and the clinical expression of Alzheimer disease: The nun study
22. Atherosclerosis, Apoplipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study
23. Cerebral Infarcts in patients with autopsy-proven Alzheimer's Disease: CERAD, part XVIII
24. Which vascular lesions are of importance in vascular dementia?
25. Clinicopathologic studies of primary cerebral amyloid angiopathy
26. Relationship between ApoE, MRI findings, and cognitive function in the cardiovascular health study
27. Medial temporal lobe atrophy in stroke patients: Relation to pre-existing dementia
28. Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: A volumetric magnetic resonance imaging study
29. Comparative MR analysis of the entorrhinal cortex and hippocampus in diagnosing Alzheimer disease
30. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias
31. Neuropsychiatric manifestations of patients with Cushing's syndrome
32. Cognitive decline in patients with Cushing's syndrome
33. General intelligence and cognitive profile in women with congenital adrenal hyperplasia
34. Androgen effects on cognition: Congenital adrenal hyperplasia
35. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro
36. Effects of glucocorticoids on oxidative stress-induced hippocampal cell death: Implications for the pathogenesis of Alzheimer's disease
37. Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures
38. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation, from obesity to memory deficits
39. Anaylsis of agonist and antagonist activities of pheylglycine derivatives for different cloned metabotropic glutamate receptor subtypes
40. Pharmacological agents acting at subtypes of metabotropic glutamate receptors
41. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage
42. Cytotoxic effects of acidic and sulphur-containing amino acids on the infant mouse central nervous system
43. Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia
44. Stress, glucocorticoids, and damage to the nervous system: The current state of confusion
45. Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus
46. Glucocorticoid endangement of hippocampal neurons is NMDA-receptor dependent
47. Increased cortisol levels and impaired cognition in human aging; implication for depression and dementia in later life
48. A synaptic model of memory: Long-term potentiation in the hippocampus
49. NMDA receptor subunits in the postsynaptic density of rat brain: Expression and phosphorylation by endogenous protein kinases
50. Brain-derived neurotrophic factor enhances association of protein tyrosine phosphatase PTP1D with the NMDA receptor subunit NR2B in the cortical postsynaptic density
51. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites
52. Evidence for NMDA and mGlu receptor-dependent long-term potentiation of mossy fiber-granule cell transmission in rat cerebellum
53. Rapid, synaptically driven increases in the intrinsic excitability of cerebellar deep nuclear neurons
54. Long-term potentiation of intrinsic excitability at the mossy fiber-granule cell synapse of rat cerebellum
55. The glutamate uptake blocker DL-threo-3-hydroxyaspartate reduces NMDA receptor activation by glutamate in cultured neurons
56. The nerve growth factor 35 years later
57. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family
58. NT-3, BDNF, and NGF in the developing rat nervous system: Parellel as well as reciprocal patterns of expression
59. Molecular cloning of a human gene that is a member of the nerve growth factor family
60. Primary structure and biological activity of a novel human neurotrophic factor
61. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary
62. Neurotrophin signal tranduction by Trk receptor
63. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor
64. TrkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3
65. The trk proto-oncogene encodes a receptor for nerve growth factor
66. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule cell neurons and protects them against glutamate-induced neurotoxicity
67. Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate
68. N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis
69. Respiratory chain inhibition induces tolerance to focal cerebral ischemia
70. Genomic response to growth factors
71. Function and activation of NF-κB in the immune system
72. Synaptic activation of NF-κB by glutamate in cerebellar granule neurons in vitro
73. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons
74. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
75. Induction of NF-κB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: Suppression of NF-κB and neuroprotection by antioxidants
76. Inhibition of nuclear factor kappa B (NfkappaB) activity induces nerve growth factor-resistant apoptosis in PC12 cells
77. An essential role for NF-κB in preventing TNF-κ-induced cell death
78. More hippocampal neurons in adult mice living in an enriched environment
79. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus
80. Experience-induced neurogenesis in the senescent dentate gyrus
81. Experience-dependent regulation of adult hippocampal neurogenesis: Effects of long-term stimulation and stimulus withdrawal
82. Brain plasticity and stroke rehabilitation. The Willis lecture
83. Evolution of functional reorganization in hemiplegic stroke: A serial positron emission tomographic activation study
84. Cortical plasticity after stroke: Implications for rehabilitation
85. Stroke. Neurologic and functional recovery the Copenhagen Stroke Study
86. Bihemispheric contribution to motor recovery after stroke: A longitudinal study with transcranial Doppler ultrasonography
87. Gait in stroke: Assessment and rehabilitation
88. Mapping clinically relevant plasticity after stroke
89. Stroke recovery. Lessons from functional MR imaging and other methods of human brain mapping
90. An integrative neuroimaging approach to restorative neurology
91. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome
92. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density
93. Inhibition of dendritic spine induction on hippocampal CA1 pyramidal neurons by a nonsteroidal estrogen antagonist in female rats
94. Subunit- and site-specific pharmacology of the NMDA receptor channel